• The company excels at cultivation and works to control its own supply chain in order to ensure certified organic products and quality for hemp-derived CBD and marijuana
• Green Hygienics Holdings’ mission is to provide best-in-class medical and recreational consumers with premier cannabis products

A full-scope, premium cannabis cultivation business, Green Hygienics Holdings Inc. (OTCQB: GRYN) is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company’s goal is to provide medical and recreational consumers with the best possible product and experience.

Green Hygienics recently announced that it has secured licenses for the cultivation and processing of hemp in the state of Michigan (http://ibn.fm/tv2V9). These licenses were granted to its two wholly owned subsidiaries, Green Hygienics Michigan LLC and Coastal Labs Michigan LLC. The licenses were granted under the Michigan Department of Agricultural and Rural Development (“MDARD”) Industrial Hemp Ag-Pilot Program launched by Governor Gretchen Whitmer.

“Obtaining these licenses is complementary to our mission of becoming a leader in the advancement of science-driven cannabis cultivation systems,” Green Hygienics’ VP of Business Development Matt Dole said in a news release. “Michigan’s strong farming community produces 300 different commodities on a commercial basis, and we are pleased to be part of its continued growth.”

The company’s long-term goals include expanding its portfolio of brands, first across the United States and then worldwide. Green Hygienics Holdings has its corporate headquarters in Poway, California.

Green Hygienics Holdings’ operational strategy is grouped into four levels.

• The first level is cultivation, and this is where the company excels in both hemp and marijuana cultivation. The company’s science team is made up of an extraordinary group with years of experience. They ensure certified organic products and quality for hemp-derived CBD (cannabidiol) and marijuana. Green Hygienics is using the advantages of hybrid aeroponics to create a sterile growing environment, which produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company has integrated and is developing its own IP (intellectual property) assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. The result is definitive efficiencies in a commercially controlled cultivation environment. Leveraging hybrid aeroponics, Green Hygienics uses high-tech, quality-controlled commercial cultivation methodologies to assure production of pharmaceutical-grade cannabis at considerably higher yields and greatly decreased costs. Hybrid aeroponics produces first-class cannabis quicker than traditional methods. In addition, it doesn’t necessitate natural sunlight or soil. Moreover, it can be operational and produce plants anywhere.
• The second level is processing, which focuses on staying as close to whole or organic as possible. Green Hygienics Holdings recently announced that it has executed an LOI with foremost CBD processor Coastal Labs LLC of Las Vegas, Nevada (http://ibn.fm/7z4Xr). Coastal Labs provides state-of-the-art extraction techniques and equipment for the cannabis industry. Furthermore, it provides wholesale distribution for clients looking to buy in bulk. With this acquisition of Coastal Labs, Green Hygienics is primed to add one of the leading labs in North America to its brand portfolio.
• The third level is dedicated to branding and brand acquisitions. The company suggests that interested parties visit its website and sign up to receive announcements.
• The fourth is Mad Marketing; there’s much more to come from this company!

Green Hygienics Holdings continues to advance its mission to provide consumers with high-quality and premium-grade cannabis products. For investors, the company’s dedication to growth through the creation of trusted international consumer brands offers the potential for significant return on investment. Green Hygienics is also working to grow in size and revenue by building a cultivation and extraction center in Canada, where legislation supports worldwide distribution.

For more information, visit the company’s website at www.GreenHygienicsHoldings.com

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://ibn.fm/GRYN

• The biopesticides market is projected to grow at a CAGR of nearly 16 percent from 2018 to 2023
• Increasing adoption of organic farming is a key driver of biopesticide market growth, with the sector expected to reach $6.4 billion by 2023
• A patented natural biopesticide developed by MustGrow targets the fruit, vegetable, turf, ornamental and cannabis industries
• Net proceeds from the recent closing of $1.2 million in non-brokered private placements will help accelerate research and development efforts

Agricultural biotech company MustGrow Biologics Corp. is focused on developing and commercializing its patented technology – a natural biopesticide and biofertilizer. MustGrow’s technologies provide an all-natural, effective, safe and easy-to-use solution for farmers in the fruit, vegetable, turf and ornamental industries looking to raise healthy crops without the use of synthetic pesticides. Cannabis cultivators, working in the rapidly evolving cannabis space, are also potential agricultural partners.

The biopesticides market is projected to grow at a compound annual growth rate of 15.99 percent from 2018 to 2023, according to a new report issued by ResearchAndMarkets (http://ibn.fm/NLeEk). Growth of the biopesticides market is driven by advancements in integrated pest management solutions and increasing adoption of organic farming techniques, the March 2019 report states. Rising concerns about the harmful effects of chemical pesticides on the environment have encouraged the adoption of organic farming methods.

MustGrow’s natural biopesticides and biofertilizers, refined from compounds of the mustard plant, act as a nematicide (chemicals used to kill nematodes, or tiny, parasitic worms), a fungicide, a pesticide and a fertilizer (http://ibn.fm/DoyNi). Its technologies deliver first-rate pest and pathogen control in combination with plant growth and yield benefits available across a wide array of crops. MustGrow’s novel and proprietary solutions provide growers with a sustainable, beneficial technology that is user-friendly and superior to synthetic alternatives.

The company recently announced the closing of a non-brokered private placement that consisted of 1,712,533 MustGrow common shares, each priced at a $0.70 per share, for gross proceeds of $1,198,773 (http://ibn.fm/fpBsD). MustGrow intends to use the net proceeds to accelerate research and development of its biopesticide and biofertilizer formulations, as well as for working capital and general corporate purposes. The company plans to direct research and development proceeds toward its patented mustard-derived signature products and its prospective suite of in-licensed natural biologics.

The global economic impact of soil-borne nematodes is estimated at nearly $100 billion in lost crops per year. The American Phytopathological Society (http://ibn.fm/ro7A6), an international nonprofit scientific organization dedicated to the study and control of plant diseases, estimates that plant-pathogenic nematodes are responsible for 14 percent of crop losses worldwide.

MustGrow’s biopesticide has U.S. EPA (Environmental Protection Agency) and Canadian PMRA (Pest Management Regulatory Agency) labels and is an approved organic solution. To date, the company has completed more than 110 independent third-party field trials. MustGrow is at the forefront of development of unique solutions to help fruit, vegetable, turf, ornamental and cannabis growers control pests and crop diseases.

For more information, visit the company’s website at www.MustGrow.ca

• Following two months on the shelf and positive consumer feedback, Meijer supermarket chain has added NGTF ice cream to additional store locations
• Nightfood ice cream quickly established distribution in 16 states
• NGTF CEO Sean Folkson was recently interviewed on the floor of the New York Stock Exchange

Nightfood Holdings Inc. (OTCQB: NGTF) is solving America’s $50 billion nighttime snacking problem with sleep-friendly nighttime ice cream. With its team of leading sleep and nutrition experts, NGTF is pioneering the projected billion dollar nighttime nutrition and sleep-friendly snack categories.

The Nightfood ice cream brand is already making a name for itself. Based on a Kantar survey of more than 40,000 consumers, NGTF ice cream was named recipient of the 2019 ‘Product of the Year’ award in the ice cream category, and it has been featured in major media outlets including USA Today, MarketWatch, The Washington Post, Food Network, Today and more.

NGTF recently announced that the Meijer supermarket chain has added Nightfood ice cream to 13 additional store locations, just two months after the product was initially launched into 95 of Meijer’s 240 high-volume supercenters (http://ibn.fm/4p7lU). Four of these locations are new Meijer Supercenters scheduled to open in May. Three of the four new stores are in Ohio and will be introducing both Meijer and Nightfood to the Cleveland market. Nightfood’s distribution with Meijer is currently concentrated around the metropolitan areas of Chicago, Detroit, Indianapolis, Columbus and Milwaukee, in addition to the three new stores in Cleveland.

Meijer Supermarket distribution is only one of many steps the company is taking toward reaching its goal of being on shelves in 10,000 locations by March 31, 2020.

After news broke of the Meijer expansion, NGTF CEO Sean Folkson was welcomed to the floor of the New York Stock Exchange to be interviewed by financial news outlet Cheddar. In an interview that aired live nationally on May 7, 2019, Folkson was asked about the potential for an acquisition of the Nightfood brand and responded, “Acquisition is really hot in the CPG (consumer packaged goods) space. We’ve seen a ton of them, they’re very frothy. We do think that by this time next year, we’re going to be in position where we’re probably going to be fielding some phone calls, and we’re certainly going to listen.“

The company also recently revealed that another billion-dollar regional chain in the Midwest, a top-50 supermarket chain with per-store revenue double that of an average Whole Foods, has also added Nightfood to its freezers in select locations. Details of that deal have not yet been announced.

For more information, visit the company’s website at www.Nightfood.com

NOTE TO INVESTORS: The latest news and updates relating to NGTF are available in the company’s newsroom at http://ibn.fm/NGTF

• Asher House co-founders recently appeared on The Ellen Show to highlight the company’s mission of moving dogs from shelters to homes
• Sales of hemp-based Asher House Thrive Oil fund dog-adoption efforts
• Through its controlling interest in Asher House Wellness, NUGS has enabled the adoption of more than 200 dogs in North America

Cannabis Strategic Ventures Inc. (OTC: NUGS) portfolio company Asher House Wellness’ co-founders, Lee Asher and Luke Barton, recently appeared on The Ellen Show to discuss their cross-country journey to rescue sheltered animals and move them into loving homes (http://ibn.fm/Nc8oE).

The two men represented the Asher House team on the broadcast, which reaches a national TV audience. The segment, titled ‘Ellen Meets Inspiring Dog Adoption Duo’, is also featured on the show’s YouTube channel. The Ellen Show currently has 31 million subscribers on YouTube.

“The more the community knows about and supports the Asher House Wellness and their industry-leading products that help dogs live well and thrive, the longer we will be able to continue our mission,” Asher noted in a news release. NUGS acquired a controlling interest in Asher House Wellness in 2018, and the company’s efforts have enabled the adoption of more than 200 dogs in the United States and Canada.

The Asher House Wellness brand consists of products for pets, including full-spectrum, whole-plant hemp that’s free of THC and pesticides. The company also plans to introduce several new dog products this year, including Lillie’s Love Biscuits.

“It is rare to find a company that is walking the talk and creating industry-leading products while also dedicating personal resources to help their mission,” CEO Simon Yu said in a news release.

Los-Angeles based NUGS incubates, develops and partners with leaders in the cannabis sector; the company has a portfolio of cannabis-related businesses. The NUGS brand experience provides operational and financial strategic partnerships and other services to existing and emerging cannabis consumer brands. The company also pursues investment opportunities in the areas of cultivation, extraction, packaging and dispensary operations within the cannabis space. NUGS is focused on cannabis industry niches and creating cannabis consumer brands.

For more information, visit the company’s website at www.CannabisStrategic.com

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://ibn.fm/NUGS

• Hemptown USA grows broad-spectrum hemp biomass using premium seed genetics
• The company aims to grow one million CBG seeds and two million CBD seeds in 2019
• It expects to expand distribution and growing operations globally

Hemptown USA is a proven grower of broad-spectrum hemp biomass. The company works meticulously with processors to produce the finest broad-spectrum CBD (cannabidiol) and CBG (cannabigerol) oils and pure isolates. Considered a novel cannabinoid, CBG is non-intoxicating and present in low levels in most cannabis strains. In fact, it is the chemical parent of both THC (tetrahydrocannabinol) and CBD, meaning that both compounds begin as CBG (http://ibn.fm/HiAix). Scientific work is continuing to identify the full range of CBG effects and the health benefits resulting from a combination of CBG and other cannabinoids (http://ibn.fm/WdEHs).

Based in Central Point, Oregon, Hemptown USA is positioned to be a top CBG producer in the United States this year and beyond. The microclimates where the company grows its hemp biomass are located in Oregon’s well-known ‘Emerald Triangle’, as well as the states of Kentucky and Colorado. These microclimates are specially selected for their perfect combinations of soil, weather and protected natural environments.

The company uses best-in-class seed genetics from Oregon CBD Seeds, which contain less than 0.3 percent THC and exceptionally high cannabidiol content of up to 20 percent. Hemptown USA’s strains include Suver Haze, Sour Space Candy and Electra.

Rod Wolterman, founder and chairman of Hemptown USA, noted in a CFN interview (http://ibn.fm/tslBq) that the company farmed 110 acres in 2018. Hemptown’s farmland for this year’s growing season has increased to approximately 1,500 acres in Oregon, Kentucky and Colorado. Hemptown USA’s goal for 2020 is 2,500 acres. Furthermore, by way of strategic partnerships, the company anticipates expanding its distribution and growing operations internationally.

A Ministry of Hemp article (http://ibn.fm/FNBh8), titled ‘Expanding US Hemp Acreage Proves Hemp Is The Next Big Cash Crop’, reported that, “in 2017, hemp fields expanded by 163 percent across the country. That’s over 25,000 acres of hemp grown across 19 different states.” The five states that made the most significant hemp acreage leaps in 2017 were New York (2,000 acres), North Dakota (3,020 acres), Kentucky (3,271 acres), Oregon (3,469 acres) and Colorado (9,700 acres).

Hemptown USA has exclusive rights to one million rare CBG seeds that are genetically programmed to yield 12-17 percent broad-spectrum, non-intoxicating cannabinoids. The company has a long-standing relationship with Oregon CBD Seeds, one of the world’s most respected cannabis-breeding enterprises. In conjunction with Oregon CBD Seeds and Hemptown USA’s product sciences team, Hemptown will aim to create custom, proprietary broad-spectrum CBD and CBG oils and pure isolates (http://ibn.fm/lKVG4).

Hemptown USA’s plans emphasize increasing in-house extraction capabilities in order to boost profit margins by providing additional CBD and CBG isolates and distillation services. Also, the company’s unique line of CBG-based products (Siskū Botanicals) is set to launch later this year.

For more information, visit the company’s website at www.HemptownUSA.com

• The global online pharmacy market is expected to continue growing rapidly through 2024, at a CAGR of 17.5 percent
• Innovative pharmaceutical solutions providers like Trxade Group are set to benefit from this trend
• Trxade Group already offers a web-based platform for supplying local independent pharmacies in the U.S., and the company’s mobile app gives patients access to same-day prescription medication deliveries

The global online pharmaceuticals market is projected to grow rapidly, at a CAGR of 17.5 percent through 2024, as detailed in a report titled ‘The Online Pharmacy Market: Global Industry Analysis’ from ResearchAndMarkets.com (http://ibn.fm/e7n2q). Several factors are expected to contribute to the growth, such as increased internet usage around the world, better health care infrastructure development and rising awareness about the benefits of ecommerce transactions.

By 2023, the global online pharmacy market is anticipated to reach $128 billion, in comparison to $29.4 billion in 2014 (http://ibn.fm/9NM9i). Companies like Trxade Group Inc. (OTCQB: TRXD) are contributing to the realization of such trends through innovative developments and easy access to user-friendly web-based services.

The Trxade online pharmaceutical purchasing platform helps independent pharmacies operating in the U.S. to identify the best possible suppliers and prices. Currently, Trxade operates the largest online pharmaceutical marketplace in the U.S. that reduces annual pharmacy purchase costs by anywhere from seven to 10 percent, on average.

To participate in the platform, pharmacies pay no fees or recurrent memberships. Additionally, the platform prioritizes the user-friendliness of its layout to ensure effortless price and supplier comparisons. Trxade Group earns from transaction fees that sellers have to pay via the platform. In addition, the company focuses on the consumer side of the pharmaceutical industry. A simplified buying process and transparency in terms of pricing are both prioritized. In addition, the company ensures reliable delivery directly to independent pharmacists and consumers.

The company continues working in that direction to offer more innovative, faster and reliable services to consumers in the U.S. Trxade Group recently announced the launch of same-day prescription deliveries via its DelivMeds app (http://ibn.fm/5KbrK). DelivMeds employs artificial intelligence (AI) to determine the best transportation methods and ensure same-day prescription deliveries. Through the app, patients can get same-day dispensed prescriptions and medication refills from local, independent pharmacists.

According to Trxade Group CEO Suren Ajjarapu, the platform is currently indirectly delivering drugs to over 12 million consumers through the company’s independent pharmacy network. The Trxade Group network of independent pharmacies features 10,250 businesses, and the target is set at 24,000 U.S. independent pharmacies.

DelivMeds is available for free download via Google Play and the Apple App Store. The app’s emphasis on local, independent pharmacies allows for personalized services and a focus on quality patient care, Ajjarapu said in a news release. Hence, the model works in the patient’s best interest, especially when people cannot wait more than a day to receive their prescription medications.

Trxade Group is an integrated pharmaceutical services company that offers a unique combination of an online purchasing platform, a network of pharmacies with E-Hub software, a mail order pharmacy and an extensive drug distributors network. The company was founded in 2010 in Tampa, Florida. Ever since the start, its primary goal has been to penetrate the extensive independent pharmacy market and diversify the company’s pharmaceutical mix with specialty and acute care products.

For more information, visit the company’s website at www.TrxadeGroup.com

NOTE TO INVESTORS: The latest news and updates relating to TRXD are available in the company’s newsroom at http://ibn.fm/TRXD

• SHRG’s new program is expected to include the creation of Spanish versions of websites and key marketing materials
• The company’s goal is to empower an independent sales force to focus on a growing Hispanic market
• SHRG’s CEO stated that the move was requested by SHRG’s Elepreneur distributors and is designed to build sales

Sharing Services Global Corporation (OTCQB: SHRG) has introduced a new marketing program for the Hispanic community, which calls for the company to create Spanish versions of key marketing materials and websites. The goal of the program (http://ibn.fm/G8dOf) is to broaden the customer and distributor base for SHRG’s Elepreneurs subsidiary.

The Hispanic market is large and projected to see significant growth in the coming years. The U.S. Census Bureau newsroom (http://ibn.fm/mzFEy) reported that, in 2017, people of Hispanic origin numbered 58.9 million, accounting for 18.1 percent of the U.S. population. In terms of spending, Latino spending in the United States will account for $1.8 trillion by 2020, according to a report by Research and Markets (http://ibn.fm/z3SJz).

“We are fulfilling the need, as requested by our Elepreneurs distributors, to have Spanish versions of electronic materials to further expand our business in the U.S.,” Sharing Services CEO John “JT” Thatch stated in a news release (http://ibn.fm/YUsnM). “Our March revenues are proof that our Blue Ocean Strategy is being well accepted in the direct-selling marketplace, and we want this growth to continue within new markets.” In March 2019, SHRG reported record sales of $10.4 million (http://ibn.fm/txTxh).

Based in Plano, Texas, SHRG owns, operates or controls a variety of companies engaged in direct selling through independent sales representatives. The company also offers services such as energy, technology and insurance. Its divisions include Elevacity Global LLC and Elepreneur LLC.

For more information, visit the company’s website at www.SHRGInc.com

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

• Kontrol Energy Corp. specializes in technology and acquisitions that improve energy usage efficiency to help clients cut costs and boost ‘good neighbor’ status
• Kontrol’s acquisitions during 2018 helped drive significant year-over-year revenue growth and record fourth quarter performance
• The company’s gross profit for the year rose by $1.8 million, thanks in large part to the activities of newly-acquired operations

Green digital technology platform developer Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) has developed its model for energy efficiency promotion into a growing, thriving operation that reported strong year-over-year growth during the past year and record revenues during the fourth quarter.

The company’s fiscal 2018 results, announced on April 30, showed a 100 percent increase in fourth quarter performance over the prior fourth quarter and a 56 percent increase for the year, as compared to the prior year (http://ibn.fm/MGCJm). That translated into a gross profit for the year of $6.4 million – an increase of $1.8 million over the previous year, largely as a result of activity from newly-acquired businesses during the 12-month stretch.

Kontrol Energy uses cutting edge technology to help companies reduce their energy costs, increase the efficiency of their energy use and improve their balance sheets. By adding company acquisitions in the building automation systems, internet of things (IoT) and HVAC technology sectors to its portfolio strategy, the energy tech business is pursuing exponential growth in 2019 in the asset and facilities management industry.

Kontrol Energy’s growth plan was highlighted in a recent agreement to create a company that provides technological solutions and services to automotive original equipment manufacturer (OEM) clients through a joint venture with Toyota Tsusho Canada Inc. (“TTCI”) – a domestic branch of the Toyota automobile group’s trading company.

The company will help clients determine how to obtain the most efficiency from their production systems and will use data analysis and machine learning to manage energy use in real-time (http://ibn.fm/rPJcO).

“Picture an automotive plant with 5,000 sensors, each of those sensors reporting something in real time… and Kontrol collects the information,” CEO Paul Ghezzi said during an interview with Follow The Money (http://ibn.fm/uZgt6). “Using that information we optimize the facility. So you’ve got really two plays there — one is a retrofit of the plant, and two is recurring revenue on a SaaS (Software as a Service) basis. So where we are is Canada, U.S. and Mexico are the markets we’ve defined. But it really is a global opportunity; at some point I think we’ll be going global with it.”

According to Ghezzi, the company’s focus on technology for buildings is acknowledgment that, in North America, buildings consume about $250 billion in energy costs each year, with expectations that, during the next decade, buildings will consume half of the energy that the world produces.

“Where that’s coming from is the move from rural to city (societies). And as cities get bigger, they consume more energy,” Ghezzi continued. “About 30 percent of all that energy is lost to inefficiencies. So call that a $60 billion market, and that’s the space that we play in.”

Research and Markets analysts forecast growth at a CAGR of 7.8 percent for the global industrial emission control systems market between 2018 and 2024 (http://ibn.fm/hgQOs). Kontrol is also entering the booming cannabis space, advising cannabis industry clients on their emissions and odor amid concerns about neighbor impacts that accompany Canada’s move to full adult-use legalization of cannabis throughout the country.

For more information, visit the company’s website at www.KontrolEnergy.com

NOTE TO INVESTORS: The latest news and updates relating to KNRLF are available in the company’s newsroom at http://ibn.fm/KNRLF

• Edward Manolos brings significant industry experience to the company
• Manolos opened the first medical marijuana dispensary in Los Angeles County in 2004
• Industry revenue is expected to reach $24.5 billion by 2021

Marijuana Company of America Inc. (OTCQB: MCOA), an industrial hemp company involved in the cultivation and distribution of hemp-derived products, recently announced the appointment of Edward Manolos as an independent director.

Joining the MCOA team of seasoned industry leaders, Manolos brings a wealth of knowledge and experience. In 2004, he opened the first-ever medical marijuana dispensary in Los Angeles County, and he is viewed (http://ibn.fm/uCEqt) as one of the “most accomplished pioneers in the medical marijuana industry.” Additionally, he is credited with starting Los Angeles’ first medicinal marijuana farmers’ market, known as the California Heritage Market, which attracted local and international media attention.

Manolos’ industry presence has been significant and varied. He has been a member of Marijuana Medical Company of America’s strategic advisory board since 2016 and has also founded several successful companies, including Everest Biosynthesis Group and Natural Plant Extracts USA (“NPE”), a significant cannabis manufacturer, distributor and retail-delivery company holding multiple licenses within the sector. He has also served as a consultant to several companies within the industry, including Cannabis Strategic Ventures (OTC: NUGS), helping these companies obtain marijuana retail and production licenses in California and Washington.

“Appointing Edward, a seasoned veteran of the cannabis industry, to our Board of Directors strategically positions us to launch our cannabis division,” Donald Steinberg, MCOA CEO, stated in a news release (http://ibn.fm/Zwchb). “His expertise in obtaining cannabis licenses, cannabis cultivation and the distribution of finished products is crucial to the development of our new subsidiary, Viva Buds, and any future projects involved in this evolving industry.”

Manolos’ appointment comes at an exciting time for the market. The cannabis and hemp industries have seen remarkable, exponential growth that is expected to continue. One major contributor to this growth has been the World Health Organization’s finding that the chemical compound cannabidiol (CBD) is nonaddictive and generally safe. In 2017, the organization officially recommended that CBD no longer be internationally scheduled as a controlled substance.

Since then, public approval of legal access to medical and recreational marijuana has grown. Industry revenue has mirrored this growth and is anticipated to more than double over the next four years at a 28 percent compound annual growth rate, reaching $24.5 billion by 2021 (http://ibn.fm/oOiBt).

For more information, visit the company’s website at www.MarijuanaCompanyofAmerica.com

NOTE TO INVESTORS: The latest news and updates relating to MCOA are available in the company’s newsroom at http://ibn.fm/MCOA

• ETST is dedicated to meeting the need for high-quality products and devices at affordable prices
• The company offers high-purity, top-quality full-spectrum CBD by utilizing seven cannabinoids that work together synergistically
• ETST is empowering women with discreet STI testing through its new, low-cost Hygee medical device kit

Florida-based biotech company Earth Science Tech Inc. (OTCQB: ETST) operates in the fields of hemp cannabinoids, nutraceuticals, pharmaceuticals, medical devices, and research and development. The company is passionate about the products that it offers and is dedicated to providing the highest-quality products and devices at affordable prices to meet a burgeoning global need.

Not all CBD products are created equal. ETST offers the highest purity and quality full-spectrum, high-grade cannabinoids on the market. Utilizing a well-branded product line and strong distribution channels that include online and retail store sales, the company is able to reach a large consumer base.

Three of ETST’s wholly owned subsidiaries focus on the medical, recreational and industrial hemp industries. These include:

• Canna Inno Laboratories Inc. accesses Canadian government funding for the advancement of further product research and development; this subsidiary allows ETST to qualify for grants offered to pharmaceutical innovators.
• Cannabis Therapeutics Inc. focuses on becoming a leader in the development of innovative CBD-based nutraceutical and pharmaceutical products.
• KannaBidoid works within the recreational cannabis space to provide a wide variety of products.

ETST products are unique in that they offer one of the highest CBD profiles of any full-spectrum hemp oil on the market. These exclusive full-spectrum products combine seven cannabinoids (http://ibn.fm/Mu0TJ), rather than the two to four that are more common in today’s market. All of ETST’s full-spectrum cannabinoid products contain CBD, CBDa, CBG, CBGa, CBN, CBC and CBDV, as well as terpenoids, amino acids, omegas, saponins and flavonoids. These individual elements work together to promote optimal results.

A recent 60-second infomercial (http://ibn.fm/LYTpv) introduces ETST’s CBD product line. The spot highlights the successful results of case studies and points viewers to where they can purchase ETST products online or in local health food stores. Thanks to recent legalizations, the company now offers products in all 50 states, as well as some 40 countries.

In addition to ETST’s work within the medicinal, pharmaceutical and hemp industries, the company is bringing to market cutting-edge pharmaceutical and medical device offerings through wholly owned subsidiary Earth Science Pharmaceutical Inc. This subsidiary focuses on the development of low-cost, non-invasive diagnostic tools, testing processes, medical devices and vaccines for sexually transmitted illnesses.

ETST’s new-to-market medical device, Hygee, was created to fight sexually transmitted infections (STIs). This self-sampling kit empowers women with discretion, enabling them to anonymously test for STIs such as chlamydia.

“No other existing method of collecting genital specimens from women is more convenient or more efficient than Hygee,” Dr. Michel Aube, ETST’s CEO and chief science officer, stated in a news release (http://ibn.fm/sUf1T). “Through intentional design, Hygee is a ‘mistake-proof’ medical device with extremely simple instructions that allow any woman, regardless of age or education, the assurance of correctly using the kit on the first try. With roughly 130 million new chlamydia cases diagnosed yearly, according to the WHO, Hygee is dedicated to this area of women’s health.”

The combination of strategic partnerships, high-quality products, a diverse portfolio, solid research and development, and a strong management team comprised of industry experts positions ETST to experience rapid growth in multiple markets.

For more information, visit the company’s website at www.EarthScienceTech.com

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at http://ibn.fm/ETST